A Study of Recombinant Oncolytic Virus M1(VRT106) in Patients With Solid Tumors
Clinical trial NCT06368921 · RECRUITING
Trial details
- NCT number
- NCT06368921
- Sponsor
- Guangzhou Virotech Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-19
- Primary completion
- 2026-09-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.